...
首页> 外文期刊>The journal of asthma >Improving asthma management: The case for mandatory inclusion of dose counters on all rescue bronchodilators
【24h】

Improving asthma management: The case for mandatory inclusion of dose counters on all rescue bronchodilators

机译:改善哮喘管理:在所有急救性支气管扩张剂上强制包含剂量计的情况

获取原文
获取原文并翻译 | 示例

摘要

Background. Asthma remains a serious global health challenge. Poor control of asthma symptoms is due in part to incorrect use of oral inhaler devices that deliver asthma medications, such as poor inhalation technique or use of a metered dose inhaler (MDI) after the recommended number of doses is expelled. Objective. To review published research on the potential for patients to overestimate or underestimate the amount of asthma rescue medication in MDIs without integrated dose-counting mechanisms. Methods. We searched PubMed and EMBASE using search terms "dose counter and asthma" and "dose counter and metered dose inhaler" for English language publications up to July, 2012, with a manual search of references from relevant articles. Results. Up to 40% of patients believe they are taking their asthma medication when they actually are activating an empty or nearly empty MDI. Device design makes it impossible for an MDI to cease delivering drug doses at an exact point, and the number of actuations in an MDI may be twice the nominal number of recommended medication doses. Once the recommended number of medication doses is expelled, remaining actuations deliver decreasing concentrations of active medication and increasing concentrations of propellants and excipients. This phenomenon, called "tail-off," is particularly problematic when medications are formulated as suspensions, as are rescue medications to control acute bronchospasm. Reliable inhalation of rescue medication could reduce asthma-related morbidity. Conclusion. By helping to ensure that patients receive accurate metered doses of asthma rescue medication to relieve bronchoconstriction, dose counters may help to improve asthma management.
机译:背景。哮喘仍然是严重的全球健康挑战。哮喘症状控制不佳的部分原因是不正确地使用了提供哮喘药物的口服吸入器设备,例如吸入技术不佳或在建议的剂量被排出后使用了计量吸入器(MDI)。目的。回顾已发表的有关在没有集成剂量计数机制的情况下患者可能高估或低估MDI中哮喘急救药物数量的研究。方法。我们使用搜索词“剂量计数器和哮喘”和“剂量计数器和计量吸入器”搜索PubMed和EMBASE,以查找截至2012年7月的英文出版物,并手动搜索相关文章的参考文献。结果。多达40%的患者认为他们实际上在激活空的或几乎空的MDI时正在服用哮喘药物。设备设计使MDI无法在精确的点停止输送药物剂量,并且MDI中的启动次数可能是推荐药物剂量标称数量的两倍。一旦排除了推荐剂量的药物,剩余的驱动力将降低活性药物的浓度,并增加推进剂和赋形剂的浓度。当药物被配制成悬浮液时,这种现象被称为“尾巴脱落”,这尤其成问题,而控制急性支气管痉挛的急救药物也是如此。可靠吸入急救药物可以减少与哮喘有关的发病率。结论。通过帮助确保患者接受准确计量的哮喘急救药物来缓解支气管狭窄,剂量计数器可以帮助改善哮喘的管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号